Genmab US, Inc

Genmab is an international biotechnology company with a core purpose to improve the lives of people with cancer and other serious diseases. Genmab’s proprietary pipeline includes bispecific T-cell engagers, next-generation immune checkpoint modulators, effector function enhanced antibodies and antibody-drug conjugates. For more information, please visit Genmab.com and follow us on Twitter.com/Genmab.